Weight-loss surgery study for people with severe obesity
Part of Hormones & metabolism clinical trials.
This trial studies bariatric (weight-loss) surgery and how well it helps people reach and keep a healthier weight. You may qualify if you have severe obesity and have not been able to maintain weight loss with other attempts, and if you can safely follow the study plan.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your body mass index (BMI) is very high: either 40 or higher, or 35 or higher with an obesity-related health problem (like type 2 diabetes, high blood pressure, sleep apnea, fatty liver, joint pain, cholesterol problems, digestive issues, or heart disease).
- You’ve tried weight-loss efforts before, but you couldn’t keep a healthy weight loss over time.
- You can give informed consent to join the research study.
- You are willing and able to return for follow-up visits during the study.
- You do not have substance abuse, uncontrolled severe mental health problems, or a plan/concern that you wouldn’t be able to follow study instructions; you also should not have advanced cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two programs for people with severe obesity: an intensive weight-loss diet and a weight-loss surgery (bariatric surgery). It aims to see which approach works better for long-term health.
This trial is building a database of people with obesity who have had or are planning to have weight loss surgery (metabolic or bariatric surgery). It helps doctors learn more about long-term results and safety.
This trial looks at obesity care in people who have already had bariatric (weight-loss) surgery or certain abdominal surgery. It may help researchers understand what treatments or follow-up care could work best for you after surgery.
This trial tests a type of weight-loss surgery (called metabolic surgery) to see if it helps people with type 2 diabetes achieve better blood sugar control. It's for people who have struggled to manage their diabetes with standard treatments and have a BMI between 30 and 35.
This study tests whether weight-loss surgery improves how your body uses insulin and energy. It compares insulin sensitivity and related measurements before and after surgery to understand who benefits.
This trial tests whether adding a GLP-1 receptor agonist (a medication that helps control blood sugar and appetite) after weight loss surgery improves outcomes for people with severe obesity and related health problems like type 2 diabetes.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.